Laurine Bergeron
Research Subjects
Laurine Bergeron has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
A. Seassau
INRAE Sophia Antipolis France
1 shared publication- Audrey Le Mestr
Ashland Specialties France, Affiliate of Ashland Inc., 06904 Sophia Antipolis, France
1 shared publication - Catherine Serre
Ashland Specialties France, Affiliate of Ashland Inc., 06904 Sophia Antipolis, France
1 shared publication E. Oger
Ashland Specialties France Sophia Antipolis France
1 shared publication- Hui Ren
R&D Center, Shanghai CHANDO Group Co., Ltd., Shanghai 200233, China
1 shared publication I. Imbert
Ashland Specialties France Sophia Antipolis France
1 shared publication
Latest Publications
- Open Access
Plant Small RNA-Rich Himalayan Anethum graveolens Extract Modulates Aging-Associated microRNA Signatures to Enhance Dermal Architecture Protein Synthesis in Human Skin
In December 2024, scientists Victor Ambros and Gary Ruvkun were awarded the Nobel Prize in Physiology or Medicine for their novel discovery of post-transcriptional gene regulation via microRNA (miRNA). This large class of non-coding RNAs defines a new layer of gene regulation activity that can control many biological processes in multicellular organisms. This experimental study explores how Himalayan Anethum graveolens extract (HAGE), rich in small RNAs, obtained by PSR technology™, can modulate human miRNAs and skin signaling pathways to improve dermal architecture and elastic fiber integrity for anti-aging benefits. Our epigenomic study analyzes skin biopsies from Chinese individuals according to different characteristics (chronological age, photoprotection…) and identifies distinct miRNA expression profiles associated with both endogenous and exogenous aging pathways using analytical and bioinformatics methodologies. Differential targeting of aging-related genes suggests that specific miRNAs may play a regulatory role in coordinating these two aging processes. Our in vitro experiments in normal human dermal fibroblasts indicate that 0.05% HAGE decreased the expression of miRNA signatures associated with intrinsic aging (miR-30c-2-3p and miR-125b-1-3p) and photoaging (miR-16-2-3p). Further in vitro and ex vivo assays, with the ex vivo findings to be regarded as preliminary, also showed increases in dermal matrix proteins such as collagen type I and III, elastin, fibrillin-1 and dermatopontin. We demonstrated that HAGE decreases key aging-associated miRNAs, including miR-30c-2-3p and miR-125b-1-3p (intrinsic aging) and miR-16-2-3p (photoaging). IGF1 and IGF1R are established miRNA targets, identified as skin endogenous aging target genes of miR-30c-2-3p and miR-125b-1-3p (invention patent ZL201810165800.7, IDP000089683) and are involved in cell growth and renewal, whereas CTGF (CCN2) is an experimentally supported target of miR-16-2-3p; however, the restoration of these target axes by HAGE was not directly measured. In ex vivo and in vitro models, HAGE increased collagen type I and III, elastin, fibrillin-1 and dermatopontin, supporting its potential regulatory impact on skin aging mechanisms. Our experiments are consistent with an epigenetic modulation model of aging prevention based on the modulation of miRNAs as aging gene-silencing agents by topical application of extracts rich in small RNAs such as HAGE. Whether plant small RNAs are taken up by and functional in human skin cells, and whether this modulation translates into clinical anti-aging benefits remains to be established.
Open AccessPlant Small RNA-Rich Himalayan Anethum graveolens Extract Modulates Aging-Associated microRNA Signatures to Enhance Dermal Architecture Protein Synthesis in Human Skin
In December 2024, scientists Victor Ambros and Gary Ruvkun were awarded the Nobel Prize in Physiology or Medicine for their novel discovery of post-transcriptional gene regulation via microRNA (miRNA). This large class of non-coding RNAs defines a new layer of gene regulation activity that can control many biological processes in multicellular organisms. This experimental study explores how Himalayan Anethum graveolens extract (HAGE), rich in small RNAs, obtained by PSR technology™, can modulate human miRNAs and skin signaling pathways to improve dermal architecture and elastic fiber integrity for anti-aging benefits. Our epigenomic study analyzes skin biopsies from Chinese individuals according to different characteristics (chronological age, photoprotection…) and identifies distinct miRNA expression profiles associated with both endogenous and exogenous aging pathways using analytical and bioinformatics methodologies. Differential targeting of aging-related genes suggests that specific miRNAs may play a regulatory role in coordinating these two aging processes. Our in vitro experiments in normal human dermal fibroblasts indicate that 0.05% HAGE decreased the expression of miRNA signatures associated with intrinsic aging (miR-30c-2-3p and miR-125b-1-3p) and photoaging (miR-16-2-3p). Further in vitro and ex vivo assays, with the ex vivo findings to be regarded as preliminary, also showed increases in dermal matrix proteins such as collagen type I and III, elastin, fibrillin-1 and dermatopontin. We demonstrated that HAGE decreases key aging-associated miRNAs, including miR-30c-2-3p and miR-125b-1-3p (intrinsic aging) and miR-16-2-3p (photoaging). IGF1 and IGF1R are established miRNA targets, identified as skin endogenous aging target genes of miR-30c-2-3p and miR-125b-1-3p (invention patent ZL201810165800.7, IDP000089683) and are involved in cell growth and renewal, whereas CTGF (CCN2) is an experimentally supported target of miR-16-2-3p; however, the restoration of these target axes by HAGE was not directly measured. In ex vivo and in vitro models, HAGE increased collagen type I and III, elastin, fibrillin-1 and dermatopontin, supporting its potential regulatory impact on skin aging mechanisms. Our experiments are consistent with an epigenetic modulation model of aging prevention based on the modulation of miRNAs as aging gene-silencing agents by topical application of extracts rich in small RNAs such as HAGE. Whether plant small RNAs are taken up by and functional in human skin cells, and whether this modulation translates into clinical anti-aging benefits remains to be established.
- 25 July 2024
- Published by Wiley in International Journal of Cosmetic Science
- Vol. 46 (6) , 962-971
Natural fermentation of fresh Jasmine flowers inspired the development of a biotechnological ingredient with global anti‐ageing properties
Objective: This study focused on the development of a new‐to‐world ingredient harnessing the natural potential of fresh Jasminum grandiflorum flowers to self‐ferment by its phytobiome revealing flower content. Analytical investigations were conducted to highlight specific phytocompounds generated during the natural fermentation of flowers in comparison to a conventional extraction. The synergy with another extraction technology maximized the generation of biocompounds for an interesting efficacy.Methods: Jasmine extract was elaborated by combining two patented technologies: the phytofermentology™, inspired by plant–microorganisms interaction and designed to develop ingredients obtained by natural fermentation of the vegetal using its own phytobiota; and the PSR™ technology allowing the extraction of bioactive phytocompounds such as small RNAs from plants.Results: Analytical investigations of Jasmine extract highlighted uniqueness and richness of the phytocompound profiles, such as organics acids and phenolic compounds, markers of fermentation only obtained after phytofermentology in comparison to conventional extraction. Jasmine extract has the particularity to contain jasmintides, flower small peptides belonging to the family of cysteine‐rich peptides (CRPs). Antioxidant and global anti‐ageing properties were investigated in cell‐free assays demonstrating interesting results: about 20% scavenging of free radicals from 0.5% of Jasmine extract and protection from DNA damage of 26% in comparison to a stressed control.Conclusion: Phytofermentology™ technology combined with PSR™ technology, meant to be respectful of the environment, allowed to development of biofunctionals very close to nature with a unique analytical signature as Jasmine extract, using the potential of fresh flowers phytobiota to self‐ferment. The efficacy of the ingredient on global antioxidation and anti‐ageing via hyaluronidase/tyrosinase inhibitions was highlighted by cell‐free evaluation assays. Further and complementary studies should be conducted to confirm the bioefficacy of this ingredient with in vitro / ex vivo assays.
- 25 July 2024
- Published by Wiley in International Journal of Cosmetic Science
- Vol. 46 (6) , 962-971
Natural fermentation of fresh Jasmine flowers inspired the development of a biotechnological ingredient with global anti‐ageing properties
Objective: This study focused on the development of a new‐to‐world ingredient harnessing the natural potential of fresh Jasminum grandiflorum flowers to self‐ferment by its phytobiome revealing flower content. Analytical investigations were conducted to highlight specific phytocompounds generated during the natural fermentation of flowers in comparison to a conventional extraction. The synergy with another extraction technology maximized the generation of biocompounds for an interesting efficacy.Methods: Jasmine extract was elaborated by combining two patented technologies: the phytofermentology™, inspired by plant–microorganisms interaction and designed to develop ingredients obtained by natural fermentation of the vegetal using its own phytobiota; and the PSR™ technology allowing the extraction of bioactive phytocompounds such as small RNAs from plants.Results: Analytical investigations of Jasmine extract highlighted uniqueness and richness of the phytocompound profiles, such as organics acids and phenolic compounds, markers of fermentation only obtained after phytofermentology in comparison to conventional extraction. Jasmine extract has the particularity to contain jasmintides, flower small peptides belonging to the family of cysteine‐rich peptides (CRPs). Antioxidant and global anti‐ageing properties were investigated in cell‐free assays demonstrating interesting results: about 20% scavenging of free radicals from 0.5% of Jasmine extract and protection from DNA damage of 26% in comparison to a stressed control.Conclusion: Phytofermentology™ technology combined with PSR™ technology, meant to be respectful of the environment, allowed to development of biofunctionals very close to nature with a unique analytical signature as Jasmine extract, using the potential of fresh flowers phytobiota to self‐ferment. The efficacy of the ingredient on global antioxidation and anti‐ageing via hyaluronidase/tyrosinase inhibitions was highlighted by cell‐free evaluation assays. Further and complementary studies should be conducted to confirm the bioefficacy of this ingredient with in vitro / ex vivo assays.